Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
HALB
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
NA
vs NA
Q1.23
N/A
NA
vs NA
Q2.23
N/A
NA
vs NA
Q3.23
N/A
NA
vs NA
Q4.23
N/A
NA
vs NA
Q1.24
N/A
NA
vs NA
Q2.24
N/A
NA
vs NA
Q3.24
N/A
NA
vs NA
Q4.24
N/A
NA
vs NA
Q1.25
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q4.22
-75%
913 vs 3.6K
Q1.23
-88%
126 vs 1.1K
Q2.23
-35%
786 vs 1.2K
Q3.23
-58%
900 vs 2.1K
Q4.23
-82%
165 vs 913
Q1.24
+562%
834 vs 126
Q2.24
-100%
NA vs 786
Q3.24
-100%
NA vs 900
Q4.24
-100%
NA vs 165
Q1.25
-100%
NA vs 834
Return on Equity
QoQ
Q2.23
+9%
0.09
vs 0.12
Q3.23
+3%
0.03
vs 0.09
Q4.23
+6%
0.06
vs 0.03
Q1.24
+1%
0.01
vs 0.06
Q2.24
+1%
0.01
vs 0.01
Q3.24
+1%
0.01
vs 0.01
Q4.24
+1%
0.01
vs 0.01
Q1.25
+0%
0
vs 0.01
Institutionnal Ownership
prismmediawire.com
7 hours ago
prismmediawire.com
7 hours ago
prismmediawire.com
7 hours ago
prismmediawire.com
8 hours ago
globenewswire.com
8 hours ago
prismmediawire.com
8 hours ago
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
OTC
0.00Â ( 2.46%)
Relative Strenght
Volume Buzz
-50%
Earning Acce
No
Dist 52w H.
75%Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
HALB
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics